EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches

Biswajit Naik iD, Welka Sahu iD, Guneswar Sethi, Cherish Prashar iD, Gajendra Mohan Baldodiya iD, Jyoti Poswal iD, Chandi C Mandal iD, Jeong Ho Hwang iD, Kailash C Panday, K Sony Reddy iD, Dhaneswar Prusty iD

Chemical Biology & Drug Design · 2026-07 · 108 (1)

DOI: 10.1111/cbdd.70364 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-07-21. Written by Biswajit Naik and 10 co-authors. Institution: Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India. Major MEDLINE topics: Plasmodium falciparum, Antimalarials, DNA Gyrase, Topoisomerase II Inhibitors. 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Indian Council of Medical Research.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The global spread of drug‐resistant Plasmodium falciparum , particularly artemisinin‐resistant strains, underscores the urgent need for novel antimalarial agents with distinct mechanisms of action and improved therapeutic potential. In this study, we employed an integrated in silico and in vitro strategy to identify compounds with inhibitory activity against P. falciparum apicoplast Gyrase B (PfGyrB). High‐throughput virtual screening identified hit compounds with favorable predicted interactions against the target protein, which were subsequently evaluated using biochemical ATPase inhibition and parasite growth inhibition assays. UNC8153 and Fexofenadine hydrochloride demonstrated time‐dependent antiplasmodial activity, with lower IC 50 values at 96 h than at 48 h under prolonged exposure conditions. UNC8153 exhibited greater antiplasmodial activity (~25‐fold) than the reference compound novobiocin during the second intraerythrocytic cycle. Morphological analysis indicated impaired parasite development during the second intraerythrocytic cycle under prolonged exposure conditions. Importantly, UNC8153 retained inhibitory activity against the artemisinin‐resistant C580Y strain and exhibited minimal cytotoxicity toward HEK‐293 cells under the tested experimental conditions. Structural similarity analysis indicated that the identified compounds are chemically distinct from currently used antimalarial drugs, supporting their structural novelty. Collectively, these findings identify UNC8153 as a structurally distinct new antiplasmodial scaffold warranting further mechanistic, pharmacological, and in vivo evaluation.

Subjects

MeSH terms (MEDLINE)

Plasmodium falciparumAntimalarialsDNA GyraseTopoisomerase II InhibitorsHumansHEK293 CellsDrug DiscoveryMolecular Docking SimulationDrug ResistanceProtozoan Proteins

Author keywords

Gyrase B inhibitorsantimalarial drug discoverydrug resistancemalariaplasmodium falciparum

Substances

AntimalarialsDNA GyraseTopoisomerase II InhibitorsProtozoan Proteins

Authors and institutions

  • Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India.
  • School of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar, Odisha, India.
  • Animal Biotechnology and Genomics Division, National Institute of Animal Science, Rural Development Administration, Jeonbuk State, Republic of Korea.
  • ICMR-National Institute of Malaria, New Delhi, India.
  • Academy of Scientific and Innovative Research (AcSIR), Gaziabad, India.
  • Department of Animal Science and Technology, Konkuk University, Seoul, Republic of Korea.

ORCID profiles: Biswajit Naik, Welka Sahu, Cherish Prashar, Gajendra Mohan Baldodiya, Jyoti Poswal, Chandi C Mandal, Jeong Ho Hwang, K Sony Reddy, Dhaneswar Prusty

Funding

  • Indian Council of Medical Research

Cite

APA

Naik, B., Sahu, W., Sethi, G., Prashar, C., Baldodiya, G. M., Poswal, J., Mandal, C. C., Hwang, J. H., Panday, K. C., Reddy, K. S., & Prusty, D. (2026). Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70364

Vancouver

Naik B, Sahu W, Sethi G, Prashar C, Baldodiya GM, Poswal J, et al. Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70364

BibTeX
@article{Naik2026,
  author = {Naik, Biswajit and Sahu, Welka and Sethi, Guneswar and Prashar, Cherish and Baldodiya, Gajendra Mohan and Poswal, Jyoti and Mandal, Chandi C and Hwang, Jeong Ho and Panday, Kailash C and Reddy, K Sony and Prusty, Dhaneswar},
  title = {Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {1},
  doi = {10.1111/cbdd.70364}
}
Start for free →